{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:53:43Z","timestamp":1794581623037,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["RCYX20221008092935096"],"award-info":[{"award-number":["RCYX20221008092935096"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82422027, U24A20340, 82171197, 82301380"],"award-info":[{"award-number":["82422027, U24A20340, 82171197, 82301380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301380"],"award-info":[{"award-number":["82301380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108013, 82327809"],"award-info":[{"award-number":["82020108013, 82327809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41380-025-02976-4","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T12:01:02Z","timestamp":1743508862000},"page":"3988-3997","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Higher plasma soluble TREM2 correlates with reduced cerebral tau accumulation in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"30","author":[{"given":"Guoyu","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7793-224X","authenticated-orcid":false,"given":"Anqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7897-9456","authenticated-orcid":false,"given":"Fernando","family":"Gonzalez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9321-3632","authenticated-orcid":false,"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9883-1616","authenticated-orcid":false,"given":"Kun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanxun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-4193","authenticated-orcid":false,"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-1991","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7904-2746","authenticated-orcid":false,"given":"Pengcheng","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2982-0865","authenticated-orcid":false,"given":"Tengfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"2976_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19:622\u201335.","journal-title":"Nat Rev Neurosci"},{"key":"2976_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","volume":"18","author":"AM Amaia","year":"2019","unstructured":"Amaia AM, De Strooper B. The role of astroglia in Alzheimer\u2019s disease: pathophysiology and clinical implications. Lancet Neurol. 2019;18:406\u201314.","journal-title":"Lancet Neurol"},{"key":"2976_CR3","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1007\/s00259-022-05897-4","volume":"49","author":"G Salvad\u00f3","year":"2022","unstructured":"Salvad\u00f3 G, Mil\u00e0-Alom\u00e0 M, Shekari M, Ashton NJ, Operto G, Falcon C, et al. Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer\u2019s continuum. Eur J Nucl Med Mol Imaging. 2022;49:4567\u201379.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2976_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1309-z","volume":"15","author":"SC Hopp","year":"2018","unstructured":"Hopp SC, Lin Y, Oakley D, Roe AD, DeVos SL, Hanlon D, et al. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer\u2019s disease. J Neuroinflammation. 2018;15:269.","journal-title":"J Neuroinflammation"},{"key":"2976_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023;615:668\u201377.","journal-title":"Nature"},{"key":"2976_CR6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jamaneurol.2023.3530","volume":"80","author":"RN Taddei","year":"2023","unstructured":"Taddei RN, Perbet R, Mate de Gerando A, Wiedmer AE, Sanchez-Mico M, Connors Stewart T, et al. Tau oligomer-containing synapse elimination by microglia and astrocytes in Alzheimer disease. JAMA Neurol. 2023;80:1209.","journal-title":"JAMA Neurol"},{"key":"2976_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575:669\u201373.","journal-title":"Nature"},{"key":"2976_CR8","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, et al. Microglial activation and tau propagate jointly across Braak stages. Nat Med. 2021;27:1592\u20139.","journal-title":"Nat Med"},{"key":"2976_CR9","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216987","volume":"15","author":"D Biel","year":"2023","unstructured":"Biel D, Su\u00e1rez-Calvet M, Hager P, Rubinski A, Dewenter A, Steward A, et al. sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer\u2019s disease. EMBO Mol Med. 2023;15:e16987.","journal-title":"EMBO Mol Med"},{"key":"2976_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"2976_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Su\u00e1rez-Calvet M, Czirr E, Lohmann E, Cuyvers E, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6:23.","journal-title":"Sci Transl Med"},{"key":"2976_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"2976_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.202012308","volume":"12","author":"M Ewers","year":"2020","unstructured":"Ewers M, Biechele G, Su\u00e1rez\u2010Calvet M, Sacher C, Blume T, Morenas\u2010Rodriguez E, et al. Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation. EMBO Mol Med. 2020;12:1\u201314.","journal-title":"EMBO Mol Med"},{"key":"2976_CR14","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43587-022-00310-z","volume":"2","author":"JB Pereira","year":"2022","unstructured":"Pereira JB, Janelidze S, Strandberg O, Whelan CD, Zetterberg H, Blennow K, et al. Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer\u2019s disease pathology. Nat Aging. 2022;2:1138\u201344.","journal-title":"Nat Aging"},{"key":"2976_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Su\u00e1rez\u2010Calvet","year":"2016","unstructured":"Su\u00e1rez\u2010Calvet M, Kleinberger G, Araque Caballero M\u00c1, Brendel M, Rominger A, Alcolea D, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol Med. 2016;8:466\u201376.","journal-title":"EMBO Mol Med"},{"key":"2976_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2018.03.003","volume":"319","author":"LM Bekris","year":"2018","unstructured":"Bekris LM, Khrestian M, Dyne E, Shao Y, Pillai JA, Rao SM, et al. Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease. J Neuroimmunol. 2018;319:19\u201327.","journal-title":"J Neuroimmunol"},{"key":"2976_CR17","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1093\/brain\/awab332","volume":"144","author":"H-H Tsai","year":"2021","unstructured":"Tsai H-H, Chen Y-F, Yen R-F, Lo Y-L, Yang K-C, Jeng J-S, et al. Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau. Brain. 2021;144:3371\u201380.","journal-title":"Brain"},{"key":"2976_CR18","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet AL, Mil\u00e0-Alom\u00e0 M, Vrillon A, Ashton NJ, Pascoal TA, Lussier F, et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol. 2021;78:1471\u20131483.","journal-title":"JAMA Neurol"},{"key":"2976_CR19","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/brain\/awab223","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, et al. Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain. 2021;144:3505\u201316.","journal-title":"Brain"},{"key":"2976_CR20","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awae035","volume":"147","author":"P S\u00e1nchez-Juan","year":"2024","unstructured":"S\u00e1nchez-Juan P, Valeriano-Lorenzo E, Ruiz-Gonz\u00e1lez A, Pastor AB, Rodrigo Lara H, L\u00f3pez-Gonz\u00e1lez F, et al. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. Brain. 2024;147:1667\u201379.","journal-title":"Brain"},{"key":"2976_CR21","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202217123","volume":"15","author":"G Salvad\u00f3","year":"2023","unstructured":"Salvad\u00f3 G, Ossenkoppele R, Ashton NJ, Beach TG, Serrano GE, Reiman EM, et al. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads. EMBO Mol Med. 2023;15:e17123.","journal-title":"EMBO Mol Med"},{"key":"2976_CR22","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, et al. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat Med. 2023;29:1775\u201381.","journal-title":"Nat Med"},{"key":"2976_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2011.50","volume":"2","author":"CJ Garwood","year":"2011","unstructured":"Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W. Astrocytes are important mediators of A\u03b2-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2011;2:1\u20139.","journal-title":"Cell Death Dis"},{"key":"2976_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13195-024-01458-z","volume":"16","author":"Z Liu","year":"2024","unstructured":"Liu Z, Shi D, Cai Y, Li A, Lan G, Sun P, et al. Pathophysiology characterization of Alzheimer\u2019s disease in South China\u2019s aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS). Alzheimers Res Ther. 2024;16:84.","journal-title":"Alzheimers Res Ther"},{"key":"2976_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, et al. Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol. 2021;141:709\u201324.","journal-title":"Acta Neuropathol"},{"key":"2976_CR26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/alz.12236","volume":"17","author":"TK Karikari","year":"2021","unstructured":"Karikari TK, Emer\u0161i\u010d A, Vrillon A, Lantero-Rodriguez J, Ashton NJ, Kramberger MG, et al. Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer\u2019s disease diagnosis. Alzheimer\u2019s Dement. 2021;17:755\u201367.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2976_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Su\u00e1rez-Calvet","year":"2019","unstructured":"Su\u00e1rez-Calvet M, Morenas-Rodr\u00edguez E, Kleinberger G, Schlepckow K, Caballero M\u00c1A, Franzmeier N, et al. Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Mol Neurodegener. 2019;14:1\u201314.","journal-title":"Mol Neurodegener"},{"key":"2976_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201809712","volume":"10","author":"M Su\u00e1rez-Calvet","year":"2018","unstructured":"Su\u00e1rez-Calvet M, Capell A, Araque Caballero M\u00c1, Morenas-Rodr\u00edguez E, Fellerer K, Franzmeier N, et al. CSF progranulin increases in the course of Alzheimer\u2019s disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol Med. 2018;10:1\u201321.","journal-title":"EMBO Mol Med"},{"key":"2976_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, S\u00e9gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968\u201380.","journal-title":"Neuroimage"},{"key":"2976_CR30","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1007\/s00259-024-06835-2","volume":"51","author":"A Li","year":"2024","unstructured":"Li A, Zhao R, Zhang M, Sun P, Cai Y, Zhu L, et al. [18F]-D3FSP \u03b2-amyloid PET imaging in older adults and alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2024;51:3990\u20134000. https:\/\/doi.org\/10.1007\/s00259-024-06835-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2976_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2967\/jnumed.114.148981","volume":"56","author":"SM Landau","year":"2015","unstructured":"Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, et al. Measurement of longitudinal \u03b2-amyloid change with 18 F-florbetapir PET and standardized uptake value ratios. J Nucl Med. 2015;56:567\u201374.","journal-title":"J Nucl Med"},{"key":"2976_CR32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","volume":"157","author":"A Maass","year":"2017","unstructured":"Maass A, Landau S, Baker SL, Horng A, Lockhart SN, La Joie R, et al. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease. Neuroimage. 2017;157:448\u201363.","journal-title":"Neuroimage"},{"key":"2976_CR33","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1212\/WNL.0000000000207369","volume":"101","author":"J Du","year":"2023","unstructured":"Du J, Li A, Shi D, Chen X, Wang Q, Liu Z, et al. Association of APOE -\u03b54, osteoarthritis, \u03b2-amyloid, and tau accumulation in primary motor and somatosensory regions in Alzheimer disease. Neurology. 2023;101:e40\u2013e49.","journal-title":"Neurology"},{"key":"2976_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13195-020-00665-8","volume":"12","author":"T Guo","year":"2020","unstructured":"Guo T, Korman D, La Joie R, Shaw LM, Trojanowski JQ, Jagust WJ, et al. Normalization of CSF pTau measurement by A\u03b240 improves its performance as a biomarker of Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12:97.","journal-title":"Alzheimers Res Ther"},{"key":"2976_CR35","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"2013","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences (2nd Edition). Routledge; 2013."},{"key":"2976_CR36","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209205","volume":"102","author":"Y Cai","year":"2024","unstructured":"Cai Y, Shi D, Lan G, Chen L, Jiang Y, Zhou L, et al. Association of \u03b2-amyloid, microglial activation, cortical thickness, and metabolism in older adults without dementia. Neurology. 2024;102:e209205.","journal-title":"Neurology"},{"key":"2976_CR37","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","volume":"131","author":"L Piccio","year":"2016","unstructured":"Piccio L, Deming Y, Del-\u00c1guila JL, Ghezzi L, Holtzman DM, Fagan AM, et al. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status. Acta Neuropathol. 2016;131:925\u201333.","journal-title":"Acta Neuropathol"},{"key":"2976_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI158708","volume":"132","author":"A Zhao","year":"2022","unstructured":"Zhao A, Jiao Y, Ye G, Kang W, Tan L, Li Y, et al. Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer\u2019s disease. J Clin Invest. 2022;132:1\u201311.","journal-title":"J Clin Invest"},{"key":"2976_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neulet.2018.08.038","volume":"686","author":"D Liu","year":"2018","unstructured":"Liu D, Cao B, Zhao Y, Huang H, McIntyre RS, Rosenblat JD, et al. Soluble TREM2 changes during the clinical course of Alzheimer\u2019s disease: a meta-analysis. Neurosci Lett. 2018;686:10\u201316.","journal-title":"Neurosci Lett"},{"key":"2976_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2020.627931","volume":"7","author":"E Ferri","year":"2021","unstructured":"Ferri E, Rossi PD, Geraci A, Ciccone S, Cesari M, Arosio B. The sTREM2 concentrations in the blood: a marker of neurodegeneration? Front Mol Biosci. 2021;7:1\u20136.","journal-title":"Front Mol Biosci"},{"key":"2976_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molmed.2018.11.006","volume":"25","author":"SF Carter","year":"2019","unstructured":"Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte biomarkers in Alzheimer\u2019s disease. Trends Mol Med. 2019;25:77\u201395.","journal-title":"Trends Mol Med"},{"key":"2976_CR42","first-page":"1","volume":"2","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Frontzkowski L, Moore A, Hohman TJ, Morenas-rodriguez E, Nuscher B, et al. Higher CSF sTREM2 attenuates ApoE4- related risk for cognitive decline and neurodegeneration. Mol Neurodegener. 2020;2:1\u201310.","journal-title":"Mol Neurodegener"},{"key":"2976_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav6221","volume":"11","author":"M Ewers","year":"2019","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med. 2019;11:eaav6221.","journal-title":"Sci Transl Med"},{"key":"2976_CR44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E Morenas-Rodr\u00edguez","year":"2022","unstructured":"Morenas-Rodr\u00edguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Su\u00e1rez-Calvet M, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study. Lancet Neurol. 2022;21:329\u201341.","journal-title":"Lancet Neurol"},{"key":"2976_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07882-8","volume":"10","author":"L Zhong","year":"2019","unstructured":"Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model. Nat Commun. 2019;10:1\u201316.","journal-title":"Nat Commun"},{"key":"2976_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.25385","volume":"85","author":"T Ohara","year":"2019","unstructured":"Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, et al. Serum soluble triggering receptor expressed on myeloid cells 2 as a biomarker for incident dementia: the hisayama study. Ann Neurol. 2019;85:47\u201358.","journal-title":"Ann Neurol"},{"key":"2976_CR47","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"SH Lee","year":"2021","unstructured":"Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron. 2021;109:1283\u20131301.e6.","journal-title":"Neuron"},{"key":"2976_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42505-x","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang L, Yang J, Meng L, Chen J, Zhou L, et al. Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer\u2019s disease. Nat Commun. 2023;14:6670.","journal-title":"Nat Commun"},{"key":"2976_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang LL, Fan X, Li L, Li X, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14:1\u201315.","journal-title":"Sci Transl Med"},{"key":"2976_CR50","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/brain\/awaa021","volume":"143","author":"EN Wilson","year":"2020","unstructured":"Wilson EN, Swarovski MS, Linortner P, Shahid M, Zuckerman AJ, Wang Q, et al. Soluble TREM2 is elevated in Parkinson\u2019s disease subgroups with increased CSF tau. Brain. 2020;143:932\u201343.","journal-title":"Brain"},{"key":"2976_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","volume":"11","author":"M Su\u00e1rez-Calvet","year":"2019","unstructured":"Ashton NJP levels of soluble T and neurofilament light chain in T rare variant carriers, Su\u00e1rez-Calvet M, Heslegrave A, Hye A, Razquin C, Pastor P, et al. Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers. Alzheimer\u2019s Res Ther. 2019;11:1\u20137.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2976_CR52","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1002\/alz.12879","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Vermunt L, Gordon BA, Pedrini S, Boonkamp L, Armstrong NJ, et al. Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer\u2019s disease: associations with A\u03b2-PET, neurodegeneration, and cognition. Alzheimer\u2019s Dement. 2023;19:2790\u2013804.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2976_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/alz.13450","volume":"20","author":"W Pelkmans","year":"2023","unstructured":"Pelkmans W, Shekari M, Brugulat\u2010Serrat A, S\u00e1nchez\u2010Benavides G, Minguill\u00f3n C, Fauria K, et al. Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer\u2019s disease progression. Alzheimer\u2019s Dement. 2023;20:483\u201393.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2976_CR54","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/brain\/awac128","volume":"146","author":"J Stevenson-Hoare","year":"2023","unstructured":"Stevenson-Hoare J, Heslegrave A, Leonenko G, Fathalla D, Bellou E, Luckcuck L, et al. Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer\u2019s disease. Brain. 2023;146:690\u20139.","journal-title":"Brain"},{"key":"2976_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2108870119","volume":"119","author":"SR Saroja","year":"2022","unstructured":"Saroja SR, Gorbachev K, Julia T, Goate AM, Pereira AC. Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation. Proc Natl Acad Sci. 2022;119:1\u201312.","journal-title":"Proc Natl Acad Sci"},{"key":"2976_CR56","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1038\/s41380-020-0817-2","volume":"26","author":"L Lemoine","year":"2021","unstructured":"Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, et al. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer\u2019s disease variants: A\u03b2PParc and PSEN1DE9. Mol Psychiatry. 2021;26:5609\u201319.","journal-title":"Mol Psychiatry"},{"key":"2976_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01900-7","volume":"17","author":"X Taylor","year":"2020","unstructured":"Taylor X, Cisternas P, You Y, You Y, Xiang S, Marambio Y, et al. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy. J Neuroinflammation. 2020;17:1\u201318.","journal-title":"J Neuroinflammation"},{"key":"2976_CR58","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/glia.23664","volume":"67","author":"TR Jay","year":"2019","unstructured":"Jay TR, von Saucken VE, Mu\u00f1oz B, Codocedo JF, Atwood BK, Lamb BT, et al. TREM2 is required for microglial instruction of astrocytic synaptic engulfment in neurodevelopment. Glia. 2019;67:1873\u201392.","journal-title":"Glia"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02976-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02976-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02976-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:13:02Z","timestamp":1757160782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02976-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2976"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-02976-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The GHABS study was approved by institutional review boards of the Shenzhen Bay Laboratory Medical Ethical Committee, and written informed consent was obtained for ethical considerations. The study was conducted in accordance with the principles of the Declaration of Helsinki and subsequent revisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants signed the written informed consent form for the GHABS project.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}